Miller, P., Tang, Y., McKinney, D., Slabicki, M., Puram, R., Sperling, A., Lee, M., Roth, J., Gould, A., Oh, E. (2025). Engineering dual-specificity PPM1D inhibitors to enhance therapeutic response and overcome chemoresistance in TP53-mutant malignancies. Blood. https://doi.org/10.1182/blood-2025-5048